心脏移植患者的电疗法:应该避免还是接受?
Evan Ketcham1, Oliver M Glass2, Adriana P Hermida3
1From the Department of Psychiatry, Dartmouth Hitchcock Medical Center, Lebanon, NH.
The journal of ECT
|August 10, 2023
概括
电疗法 (ECT) 可以成为心脏移植患者严重抑郁症的安全有效治疗方法. 虽然发生了血液动力学变化,但在本文献综述中没有报告严重的心脏并发症.
科学领域:
- 心脏病学 心脏病学
- 精神病学是一个精神病学.
- 移植医学 移植医学
背景情况:
- 患有心脏病的患者患抑郁症的风险更高.
- 电疗法 (ECT) 对严重抑郁症有效,但可能导致血液动力学变化.
- 心脏移植患者有独特的生理考虑,由于心脏无神经.
研究的目的:
- 总结有关心脏移植患者使用ECT的现有文献.
- 评估ECT在这个特定患者群体中的安全性和有效性.
主要方法:
- 在6个在线数据库中进行了文献搜索.
- 搜索的重点是心脏移植患者ECT的英语病例报告.
主要成果:
- 确定了六个案例报告.
- 所有患者在ECT期间和之后都经历了血液动力学波动 (血压变化).
- 没有报告任何严重的心脏并发症.
- 五名患者的抑郁症状有所改善.
结论:
- 在心脏移植接受者中,ECT可能是严重抑郁症的可行治疗选择.
- 必须仔细权衡ECT的潜在好处与风险.
- 有限的病例数据表明,在这个人群中,ECT可能相对安全和有效.
相关概念视频
Electroconvulsive Therapy
69
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
69
Heart Failure VI: Adjunct Therapies
16
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
16
Kidney Transplant I: Introduction
29
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
29
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
45
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
45
Cardiomyopathy V: Interprofessional Care
16
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
16
Heart Failure Drugs: Inotropic Agents
622
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
622


